Charles Gore, Founder Of World Hepatitis Alliance, To Head Medicines Patent Pool
— 2018-04-19The Medicines Patent Pool announced today that it has appointed Charles Gore as new executive director.
Continue Reading ...The Medicines Patent Pool announced today that it has appointed Charles Gore as new executive director.
Continue Reading ...Prof. Carlos Correa of Argentina, an influential academic whose analyses of patents and medicines access
Continue Reading ...The number of patents for drug delivery devices has shot up in recent years, and has had the effect of
Continue Reading ...A wide-ranging list of international nongovernmental organisations today issued a letter to European
Continue Reading ...Research collaborations between institutions in the North and institutions in the South often show a
Continue Reading ...Research collaborations between institutions in the North and institutions in the South often show a
Continue Reading ...A new affordable combination treatment for hepatitis C patients with a 97 percent cure rate was announced
Continue Reading ...Achieving a high percentage of universal health coverage often does not translate into a high quality
Continue Reading ...TAIPEI, Taiwan — The building is impressive. Taiwan’s intellectual property office, located in
Continue Reading ...A Chinese scientist has been sentenced to jail for more than 10 years for conspiring to steal samples
Continue Reading ...The World Intellectual Property Organization has chosen a new head of the Global Challenges Division,
Continue Reading ...The Universities Allied for Essential Medicines (UAEM) this week launched a campaign to ask the University
Continue Reading ...NEW YORK — A major event on innovation and access to health technologies took place at the United Nations
Continue Reading ...Nobel Prize winner Sir John Sulston passed away on 6 March at the age of 75, and was widely remembered
Continue Reading ...Access to hepatitis C treatments is increasing, so are therapeutic options, but most of those living
Continue Reading ...Pharmaceutical R&D constantly leads to the generation of new intellectual property (IP), from clinical
Continue Reading ...Intellectual property rights, particularly patents, are considered by some as being a barrier in access
Continue Reading ...The World Health Organisation’s Special Programme for Research and Training in Tropical Diseases (TDR)
Continue Reading ...The price of hepatitis C medicine marked a turning point in the discussion on access to medicines, with
Continue Reading ...Despite the widespread view that the flexibilities included in international trade rules are not being
Continue Reading ...